论文部分内容阅读
目的:分析乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果。方法:对2013年12月至2014年11月间治疗的54例重症急性胰腺炎患者为研究对象,将患者分组后采用不同的治疗方式进行治疗,并对治疗效果进行对比分析。结果:采用乌司他丁联合奥曲肽治疗的观察组总有效率为92.86%远高于采用乌司他丁治疗的76.927%,比较差异值P<0.05,具有统计学意义。结论:采用乌司他丁联合奥曲肽治疗重症急性胰腺炎具有较高的治疗有效率,提高患者的治疗质量,具有较高的治疗药用价值,值得临床推广使用。
Objective: To analyze the clinical effect of ulinastatin combined with octreotide in the treatment of severe acute pancreatitis. Methods: Fifty-four patients with severe acute pancreatitis who were treated between December 2013 and November 2014 were selected as study subjects. Patients were divided into groups and treated with different treatment methods. The therapeutic effects were compared and analyzed. Results: The total effective rate of the observation group treated with ulinastatin combined with octreotide was 92.86%, which was significantly higher than that of the group treated with ulinastatin (76.927%, P <0.05), with statistical significance. Conclusion: The treatment of severe acute pancreatitis with ulinastatin combined with octreotide has high therapeutic efficiency and improve the quality of treatment of patients with high therapeutic value, which is worthy of clinical promotion.